Development and Roll-Out of A Coronavirus Disease 2019 Clinical Pathway for Standardized Qualified Care in Public Hospitals in Korea
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kwak, M.Y. | - |
dc.contributor.author | Jo, E.Y. | - |
dc.contributor.author | Chin, B. | - |
dc.contributor.author | Park, S.E. | - |
dc.contributor.author | Yim, J. | - |
dc.contributor.author | Lee, J.E. | - |
dc.contributor.author | Jo, K.E. | - |
dc.contributor.author | Kim, Y.-S. | - |
dc.contributor.author | Lee, J.E. | - |
dc.contributor.author | Yoon, Y.K. | - |
dc.contributor.author | Seo, Y.B. | - |
dc.contributor.author | Jeong, S.J. | - |
dc.contributor.author | Kang, Y.M. | - |
dc.contributor.author | Joo, E.-J. | - |
dc.contributor.author | Yoon, J.H. | - |
dc.contributor.author | Kim, S.B. | - |
dc.contributor.author | Kim, G.Y. | - |
dc.contributor.author | Kim, M.-K. | - |
dc.date.accessioned | 2022-11-20T01:41:16Z | - |
dc.date.available | 2022-11-20T01:41:16Z | - |
dc.date.created | 2022-11-18 | - |
dc.date.issued | 2022 | - |
dc.identifier.issn | 2093-2340 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/146054 | - |
dc.description.abstract | Despite the coronavirus disease 2019 (COVID-19) vaccination roll-out, variant-related outbreaks have occurred repeatedly in Korea. Although public hospitals played a major role in COVID-19 patients' care, difficulty incorporating evolving COVID-19 treatment guidelines called for a clinical pathway (CP). Eighteen public hospitals volunteered, and a professional review board was created. CPs were formulated containing inclusion/exclusion criteria, application flow charts, and standardized order sets. After CP roll-out, key parameters improved, such as increased patient/staff five-point satisfaction scores (0.41/0.57) and decreased hospital stays (1.78 days)/medical expenses (17.5%). The CPs were updated consistently after roll-out as new therapeutics drugs were introduced and quarantine policies changed. Copyright © 2022 by The Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, and The Korean Society for AIDS This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, Korean Society for AIDS | - |
dc.title | Development and Roll-Out of A Coronavirus Disease 2019 Clinical Pathway for Standardized Qualified Care in Public Hospitals in Korea | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Yoon, Y.K. | - |
dc.identifier.doi | 10.3947/IC.2022.0026 | - |
dc.identifier.scopusid | 2-s2.0-85134558172 | - |
dc.identifier.bibliographicCitation | Infection and Chemotherapy, v.54, no.2, pp.353 - 359 | - |
dc.relation.isPartOf | Infection and Chemotherapy | - |
dc.citation.title | Infection and Chemotherapy | - |
dc.citation.volume | 54 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 353 | - |
dc.citation.endPage | 359 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002857636 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | Clinical pathways | - |
dc.subject.keywordAuthor | COVID-19 | - |
dc.subject.keywordAuthor | Hospitals | - |
dc.subject.keywordAuthor | Pandemics | - |
dc.subject.keywordAuthor | public | - |
dc.subject.keywordAuthor | SARS-CoV-2 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.